For instance, GEFT overexpression improved the proliferative, migratory, and invasive capacities of RMS cells, inhibited RMS cell apoptosis, and promoted RMS xenograft tumor growth and lung metastasis through activating Rac1/Cdc42-PAK1 pathways (10). Here, ARHGEF25 is linked to neoplasm.